Insulin lispro
Admelog, Humalog, Liprolog, Liumjev, Lyumjev (insulin lispro) is a protein pharmaceutical. Insulin lispro was first approved as Admelog on 1996-04-30. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.
| Trade Name | Humalog, Liprolog, Liumjev, Lyumjev |
|---|---|
| Common Name | Insulin lispro |
| Indication | diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus |
| Drug Class |
